Quarterly report pursuant to Section 13 or 15(d)

Balance Sheet Components (Details) - Schedule of accrued liabilities

v3.23.1
Balance Sheet Components (Details) - Schedule of accrued liabilities - USD ($)
$ in Thousands
Mar. 31, 2023
Dec. 31, 2022
Schedule Of Accrued Liabilities [Abstract]    
Accrued labor costs $ 610 $ 1,487
Accrued drug development costs 766 228
Other 322 522
Total $ 1,698 $ 2,237